CMBA
DSCI

C.M. Bidwell & Associates’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

C.M. Bidwell & Associates’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-22,825
Closed -$107K – 348
2016
Q3 		$107K Sell
22,825
-40
-0.2% -$187 0.03% 208
2016
Q2 		$90K Buy
+22,865
New +$85.4K 0.02% 195

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

C.M. Bidwell & Associates's DSCI Position: Q4 2016 in Review

C.M. Bidwell & Associates sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2016, closing a stake of 22,825 shares — an estimated $107K sold.

C.M. Bidwell & Associates first reported a position in DSCI in Q2 2016 and held it in 2 quarters. The position peaked at $107K in Q3 2016. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

  • C.M. Bidwell & Associates reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2016 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 22,825 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $107K.
  • C.M. Bidwell & Associates first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2016 and held it in 2 quarters.
  • C.M. Bidwell & Associates's Derma Sciences, Inc. Common Stock (DE) position peaked at $107K in Q3 2016.
  • 52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2016, filed 13 Feb 2017.